602 related articles for article (PubMed ID: 25597393)
1. Use of model for end-stage liver disease exceptions for donation after cardiac death graft recipients relisted for liver transplantation.
Maduka RC; Abt PL; Goldberg DS
Liver Transpl; 2015 Apr; 21(4):554-60. PubMed ID: 25597393
[TBL] [Abstract][Full Text] [Related]
2. Waitlist Outcomes for Patients Relisted Following Failed Donation After Cardiac Death Liver Transplant: Implications for Awarding Model for End-Stage Liver Disease Exception Scores.
Croome KP; Lee DD; Nguyen JH; Keaveny AP; Taner CB
Am J Transplant; 2017 Sep; 17(9):2420-2427. PubMed ID: 28556380
[TBL] [Abstract][Full Text] [Related]
3. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool.
Selck FW; Grossman EB; Ratner LE; Renz JF
Ann Surg; 2008 Oct; 248(4):599-607. PubMed ID: 18936573
[TBL] [Abstract][Full Text] [Related]
4. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
5. Center variation in the use of nonstandardized model for end-stage liver disease exception points.
Goldberg DS; Makar G; Bittermann T; French B
Liver Transpl; 2013 Dec; 19(12):1330-42. PubMed ID: 24039090
[TBL] [Abstract][Full Text] [Related]
6. Improved retransplant outcomes: early evidence of the share35 impact.
Brooks JT; Koizumi N; Neglia E; Gdoura B; Wong TW; Kwon C; Smith TE; Ortiz J
HPB (Oxford); 2018 Jul; 20(7):649-657. PubMed ID: 29500002
[TBL] [Abstract][Full Text] [Related]
7. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
Francoz C; Belghiti J; Castaing D; Chazouillères O; Duclos-Vallée JC; Duvoux C; Lerut J; Le Treut YP; Moreau R; Mandot A; Pageaux G; Samuel D; Thabut D; Valla D; Durand F
Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
[TBL] [Abstract][Full Text] [Related]
8. Survival of recipients of livers from donation after circulatory death who are relisted and undergo retransplant for graft failure.
Allen AM; Kim WR; Xiong H; Liu J; Stock PG; Lake JR; Chinnakotla S; Snyder JJ; Israni AK; Kasiske BL
Am J Transplant; 2014 May; 14(5):1120-8. PubMed ID: 24731165
[TBL] [Abstract][Full Text] [Related]
9. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
Kling CE; Perkins JD; Reyes JD; Montenovo MI
Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
[TBL] [Abstract][Full Text] [Related]
10. Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival.
Hong JC; Yersiz H; Kositamongkol P; Xia VW; Kaldas FM; Petrowsky H; Farmer DG; Lipshutz G; Markovic D; Hiatt JR; Busuttil RW
Arch Surg; 2011 Sep; 146(9):1017-23. PubMed ID: 21930997
[TBL] [Abstract][Full Text] [Related]
11. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
[TBL] [Abstract][Full Text] [Related]
12. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
[TBL] [Abstract][Full Text] [Related]
13. Attitudes and barriers to the use of donation after cardiac death livers: Comparison of a United States transplant center survey to the united network for organ sharing data.
Sher L; Quintini C; Fayek SA; Abt P; Lo M; Yuk P; Ji L; Groshen S; Case J; Marsh CL
Liver Transpl; 2017 Nov; 23(11):1372-1383. PubMed ID: 28834180
[TBL] [Abstract][Full Text] [Related]
14. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
Wong RJ; Gish RG; Ahmed A
Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation following donation after cardiac death: an analysis using matched pairs.
Pine JK; Aldouri A; Young AL; Davies MH; Attia M; Toogood GJ; Pollard SG; Lodge JP; Prasad KR
Liver Transpl; 2009 Sep; 15(9):1072-82. PubMed ID: 19718634
[TBL] [Abstract][Full Text] [Related]
16. Longterm results of liver transplantation from donation after circulatory death.
Blok JJ; Detry O; Putter H; Rogiers X; Porte RJ; van Hoek B; Pirenne J; Metselaar HJ; Lerut JP; Ysebaert DK; Lucidi V; Troisi RI; Samuel U; den Dulk AC; Ringers J; Braat AE;
Liver Transpl; 2016 Aug; 22(8):1107-14. PubMed ID: 27028896
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes in liver transplant recipients with Model for End-stage Liver Disease scores of 40 or higher: a decade-long experience.
Panchal HJ; Durinka JB; Patterson J; Karipineni F; Ashburn S; Siskind E; Ortiz J
HPB (Oxford); 2015 Dec; 17(12):1074-84. PubMed ID: 26373873
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit.
Jay CL; Skaro AI; Ladner DP; Wang E; Lyuksemburg V; Chang Y; Xu H; Talakokkla S; Parikh N; Holl JL; Hazen GB; Abecassis MM
Liver Transpl; 2012 Jun; 18(6):630-40. PubMed ID: 22645057
[TBL] [Abstract][Full Text] [Related]
19. Serum sodium and survival benefit of liver transplantation.
Sharma P; Schaubel DE; Goodrich NP; Merion RM
Liver Transpl; 2015 Mar; 21(3):308-13. PubMed ID: 25504743
[TBL] [Abstract][Full Text] [Related]
20. MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.
Marvin MR; Ferguson N; Cannon RM; Jones CM; Brock GN
Liver Transpl; 2015 May; 21(5):612-22. PubMed ID: 25694099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
